INTRODUCTION {#s1}
============

Cervical cancer is the second most deadly gynecological cancer and caused about 260,000 women's death each year \[[@R1]\]. Radical surgery is recommended as the preferred treatment for patients with cervical cancer in early stage, producing a relatively favorable prognosis \[[@R2]\]. However, patients with cervical cancer are usually diagnosed at advanced or recurrent stages with relatively poor prognosis \[[@R3]\]. Hence, exploring sensitive and specific biomarkers for prognosis is critical for the research and clinical treatment of cervical cancer.

Long noncoding RNA (lncRNA) are a kind of non-coding transcripts longer than 200 nucleotides \[[@R4]\]. LncRNAs can regulate various biological processes, such as gene expression, transcription, and cellular proliferation, through epigenetic silencing, mRNA splicing, and lncRNA-microRNA interaction \[[@R5], [@R6]\]. Furthermore, by comparing their expression of tumors and normal cells, lncRNAs are abnormally expressed in the various tumors, functioning as oncogenes or tumor suppressors \[[@R7], [@R8]\]. Recent studies have shown that lncRNAs also play important role in cervical cancer, including occurrence, progression, metastasis and prognosis \[[@R9], [@R10]\]. However, due to the sample size and research programs, singe study may be inaccurate and insufficient. With the aim to obtain a better understanding of the prognostic value of lncRNAs in patients with cervical cancer, we performed a meta-analysis to explore the prognostic value of lncRNAs through larger sample size of patients.

RESULTS {#s2}
=======

Study characteristics {#s2_1}
---------------------

As shown in Figure [1](#F1){ref-type="fig"}, we searched 191 articles in the databases. After screening the titles and abstracts, 29 full-text articles were assessed for eligibility. Then because of no usable data or incomplete data, 14 papers were excluded. As a result, a total of 15 articles were the current meta-analysis \[[@R11]--[@R25]\].

![The flow diagram indicated the process of study selection](oncotarget-08-62470-g001){#F1}

The basic information and data from the included studies are shown in Table [1](#T1){ref-type="table"} and Table [2](#T2){ref-type="table"}. 15 studies enrolling 1868 participants, with a maximum sample size of 218 and a minimum sample size of 49 patients. Among these 15 studies, 14 focused on Asians and 1 evaluated Caucasians. 9 studies reported patient overall survival (OS), 2 focused on OS as well as disease free survival (DFS), and 5 investigated OS as well as relapse free survival (RFS). DFS and RFS were combined together into event free survival (EFS) as prognosis parameter of our study. All studies investigated patients with cervical cancer and qRT-PCR was performed to detect lncRNAs expression in tumor tissues. Because the cut-off definitions were various, the cut-off values were different in these studies.

###### Basic information of included studies

  Study ID               LncRNA        Country   Dominant ethnicity   Sample   Reference   Detection method   Sample size   Outcome   Source of HR   Cut off value
  ---------------------- ------------- --------- -------------------- -------- ----------- ------------------ ------------- --------- -------------- ---------------
  Lingmin Liao 2014      XLOC_010588   China     Asian                tissue   GAPDH       qRT-PCR            218           OS/DFS    Reported&SC    median
  Long Huang 2014        HOTAIR        China     Asian                tissue   GAPDH       qRT-PCR            218           OS/DFS    Reported&SC    median
  Jing Li 2014           HOTAIR        China     Asian                tissue   GAPDH       qRT-PCR            118           OS/RFS    SC             median
  Shihong Cao 2014       GAS5          China     Asian                tissue   RNU6B       qRT-PCR            102           OS        Reported       0.29
  L. Yang 2015           MALAT1        China     Asian                tissue   GAPDH       qRT-PCR            104           OS/RFS    Reported&SC    3.075
  Meng Yang 2015         CCHE1         China     Asian                tissue   RPS18       qRT-PCR            182           OS/RFS    SC             median
  Reiko Kobayashi 2015   XIST          Japan     Asian                tissue   GAPDH       qRT-PCR            49            OS        Reported       median
  Hee Jung Kim 2015      HOTAIR        Korea     Asian                tissue   U6          qRT-PCR            111           OS        Reported       30-fold
  Shan Jiang 2015        LET           China     Asian                tissue   GAPDH       qRT-PCR            94            OS        Reported       mean
  Y.F. Wang 2016         HULC          China     Asian                tissue   GAPDH       qRT-PCR            244           OS        Reported       median
  Shaorong Zhang 2016    PVT1          China     Asian                tissue   GAPDH       qRT-PCR            90            OS        SC             median
  Marissa Iden 2016      PVT1          America   Caucasian            tissue   RPS18       qRT-PCR            121           OS        SC             median
  Hee Jung Kim 2016      HOXA11        Korea     Asian                tissue   U6          qRT-PCR            92            OS        Reported       227.5-fold
  Jun Zhang 2017         MEG3          China     Asian                tissue   β-actin     qRT-PCR            72            OS/RFS    Reported&SC    median
  Dongli Zhang 2017      ANRIL         China     Asian                tissue   GAPDH       qRT-PCR            53            OS        Reported       median

###### Summary of hazard ratios of lncRNA expression in cervical cancer

  lncRNAs       Reference               Case number   OS    DFS/RFS                                                
  ------------- ----------------------- ------------- ----- --------------------- ---------- --------------------- --------
  HOTAIR        Long Huang, 2014        109           109   4.57 (2.12--9.85)     \< 0.001   2.98 (1.62--5.45)\*   0.0004
  HOTAIR        Jing Li, 2014           59            59    3.15 (1.44--6.88)\*   0.004      2.11 (1.18--3.77)\*   0.012
  HOTAIR        Hee Jung Kim, 2015      89            22    5.28 (1.01--27.75)    0.049      NM                    NM
  PVT1          Shaorong Zhang, 2016    45            45    1.97 (1.14--3.40)\*   0.015      NM                    NM
  PVT1          Marissa Iden, 2016      63            58    1.73 (1.05--2.84)\*   0.03       NM                    NM
  XLOC_010588   Lingmin Liao, 2014      109           109   0.37 (0.17--0.75)     0.006      0.45(0.25--0.83)\*    0.008
  GAS5          Shihong Cao, 2014       58            44    3.22 (1.68--6.17)     \< 0.001   NM                    NM
  MALAT1        L. Yang, 2015           52            52    2.21 (1.08--4.56)     0.031      2.60 (1.60--4.23)\*   0.0001
  CCHE1         Meng Yang, 2015         91            91    2.27 (1.30--3.96)\*   0.004      1.23 (1.10--1.38)\*   0.0004
  XIST          Reiko Kobayashi, 2015   24            25    0.27 (0.08--0.86)     0.027      NM                    NM
  LET           Shan Jiang, 2015        44            50    0.40 (0.22--0.73)     0.003      NM                    NM
  HULC          Y.F. Wang, 2016         120           124   1.88 (1.29--2.74)\*   0.001      NM                    NM
  HOXA11        Hee Jung Kim, 2016      41            51    2.45 (1.08--5.56)     0.032      NM                    NM
  MEG3          Jun Zhang, 2017         36            36    0.33 (0.15--0.72)\*   0.005      0.16 (0.03--0.92)     0.04
  ANRIL         Dongli Zhang, 2017      27            26    3.23 (1.42--7.32)\*   0.005      NM                    NM

Analysis between lncRNAs expression level and OS {#s2_2}
------------------------------------------------

A total of 15 studies were reported that the expression levels of lncRNAs were related to OS. The random-effect model was used to assess the HRs and 95%CI. As shown in Figure [2](#F2){ref-type="fig"}, the expression levels of lncRNAs were associated with the OS of cervical cancer patients (HR = 1.56, 95%CI = 1.02--2.38, *P* \< 0.001, random-effect). From the forest plot, the high expressions of HOTAIR, PVT1, GAS5, MALAT1, CCHE1, HULC, HOXA11, ANRIL were associated with poor prognosis. Besides, XLOC_010588, XIST, LET, MEG3 were correlated to poor prognosis with the low expressions of lncRNAs in cervical cancer. With all the lncRNAs HOTAIR generate the highest HR of 5.28 \[[@R16]\]; by contrast, XIST exhibited the lowest HR of 0.27 \[[@R17]\]. Moreover, stratified analyses were performed using studies with the ethnicity. 14 articles reported the relationship between lncRNAs and Asian patents' OS (HR = 1.54, 95%CI = 0.96--2.47, *P* \< 0.01, random-effect), and 1article was about Caucasian (HR = 1.73, 95%CI = 1.05--2.85, *P* = 0.03, fixed-effect).

![Forest plot of studies evaluating hazard ratios of lncRNAs expression and the overall survival in cervical\
The point estimate is bounded by a 95% confidence interval, and the perpendicular line represents no increased risk for the outcome.](oncotarget-08-62470-g002){#F2}

In the enrolling studies, HOTAIR and PVT1 were investigated in two or more articles, other lncRNAs were performed in single study. Then we carried out a meta-analysis on the relationship between the expressions of HOTAIR/PVT1 and the OS of patients with cervical cancer. We found that the high levels of HOTAIR were associate with a poor OS (HR = 3.93, 95% CI = 2.34--6.62, *P* \< 0.001, fixed-effect) (Figure [3A](#F3){ref-type="fig"}). Meanwhile, a poor prognosis in cervical cancer was found in the increased of PVT1 (HR = 1.84, 95%CI = 1.27--2.65, *P* = 0.01, fixed-effect) (Figure [3B](#F3){ref-type="fig"})

![Forest plot of studies evaluating hazard ratios of up-regulated lncRNAs and the overall survival of cervical cancer\
(**A**) HOTAIR; (**B**) PVT1.](oncotarget-08-62470-g003){#F3}

Analysis between lncRNAs expression level and EFS {#s2_3}
-------------------------------------------------

A total of 6 studies (912 patients) included in the EFS analysis revealed a protective role increased lncRNAs expression (HR = 1.33, 95%CI = 0.77--2.28, *P* \< 0.01, random-effect) (Figure [4](#F4){ref-type="fig"}). From the forest plot, the increased expressions of HOTAIR, MALAT1 and CCHE1 correlated with a worse prognosis, the decreased expressions of XLOC_010588 and MEG3 were associated with a worse prognosis. With all the lncRNAs HOTAIR generate the highest HR of 2.98 \[[@R12]\]; by contrast, MEG3 exhibited the lowest HR of 0.16 \[[@R24]\].

![Forest plot f studies evaluating hazard ratios of lncRNAs expression and the event free survival in cervical cancer\
The point estimate is bounded by a 95% confdence interval, and the perpendicular line represents no increased risk for the outcome.](oncotarget-08-62470-g004){#F4}

Publication bias and sensitivity analysis {#s2_4}
-----------------------------------------

As shown in Figure [5](#F5){ref-type="fig"}, Begg's test was used to perform the publication bias, respectively. In our meta-analysis, Begg's test suggested there were no publication bias in all groups, owing to the values of *P* \> 0.05. Meanwhile, we used Stata11.0 software to carry out sensitivity analysis to assess whether the individual studies affected the overall results. The results suggested that individual study had little influence on our eventual outcome (Figure [6](#F6){ref-type="fig"}), and proved that our analysis was relatively stable and credible.

![Begg's test for publication bias\
(**A**) overall survival; (**B**) event free survival.](oncotarget-08-62470-g005){#F5}

![Sensitivity analyses of the studies\
(**A**) overall survival; (**B**) event free survival.](oncotarget-08-62470-g006){#F6}

DISCUSSION {#s3}
==========

Cervical cancer is one of the leading causes of cancer related death in women worldwide \[[@R26]\]. Identification of effective disease biomarkers for prognosis is urgently required. In recent years, mounting epidemiological and molecular biological studies have demonstrated that lncRNAs dysregulation was involved in cancers \[[@R27]--[@R29]\]. Furthermore, abnormal expression of multiple lncRNAs was found to be related with the tumorigenesis and may have the potential to be prognostic biomarkers and even therapeutic targets of cervical cancer \[[@R15], [@R30]\]. Therefore, we perform this meta-analysis to evaluate the prognostic ability of lncRNAs in cervical cancer.

Up to present, two meta-analysis \[[@R30], [@R31]\] assessed the correlation between lncRNAs and cancer survival involved cervical cancer as one of the cancer sites. Both of these two studies focused on exploring a single lncRNA (H19 or HOTAIR) in relation to cervical cancer. With very different goal, our article mainly aimed to evaluate the prognosis ability of all lncRNAs in cervical cancer. Therefore, the current meta-analysis is the first to evaluate the relation between lncRNAs expression and prognosis of patients with cervical cancer comprehensively.

In current meta-analysis, we evaluated the prognostic value of lncRNAs in cervical cancer. Our results suggested that high expression of lncRNAs represented a risk factor for OS and cervical cancer. Furthermore, we found that the high expressions of 8 lncRNAs were associated with poor prognosis. Besides, 4 lncRNAs were correlated to poor prognosis with the low expressions of lncRNAs in cervical cancer. Moreover, stratified analyses were performed using studies with the ethnicity. 14 articles reported the relationship between lncRNAs and Asian patents' OS (HR = 1.54,), and 1article was about Caucasian (HR = 1.73). Besides, EFS analysis also revealed a protective role decreased lncRNAs expression (HR = 1.33). Our results suggested that the expression of these lncRNAs may have a significantly prognosis value in cervical cancer. Due to the limitation of the study number, these conclusions need more clinical trials for verification.

In the enrolling studies, PVT1 and HOTAIR were investigated in two or more articles, and with the increased expression of the two lncRNAs, the prognosis rate was poor in cervical cancer. Our results revealed that PVT1 is increased in the cervical cancer patients, and the high expression of PVT1 was related with the poor prognostic outcome of cancer patients. Summary of Hazard ratios (HRs) of lncRNAs in cervical cancer patients showed that HOTAIR generate the highest HR of 5.28. HOTAIR was the first lncRNA found to be involved in tumor and has been proven to be raised in a variety of human cancers \[[@R32]\]. Meanwhile, HOTAIR is a tumorigenic factor and can be adopted as a diagnosis or predictive biomarker in various cancer types \[[@R33], [@R34]\], those findings in consist with our results. Notably, HOTAIR was the most investigated lncRNA in cervical cancer, therefore, articles explored HOTAIR as a new biomarker in the diagnosis and treatment of cervical cancer is possibly the most promising.

It should be stressed that there were limitation in our analysis. First, the number size of eligible articles is relatively small, which restrict our ability to evaluate the prognosis of lncRNAs in subgroup analyses. Second, the main ethnicities of the patients in our analysis were Asian, which also might affect the results. Third, due to positive results could be published more easily than negative results, this may lead to hidden publication bias.

In summary, the current meta-analysis was firstly to evaluate the correlation between lncRNAs and prognosis of patients with cervical cancer. Despite these limitations, there was a relationship between lncRNAs levels and OS and EFS in cervical cancer, which demonstrated the strong prognostic value of lncRNAs in cervical cancer. However, large-scale and comprehensive studies were needed to confirm our findings and thus promote the clinical utility of lncRNAs in cervical cancer prognosis evaluation.

MATERIALS AND METHODS {#s4}
=====================

Search strategy {#s4_1}
---------------

A comprehensive search was performed independently by two researchers (Xiangrong Cui and Xuan Jing) via PubMed, EMBASE and Web of Science for literatures published up to February 2017 to obtain relevant articles for the meta-analysis. The search strategy used both MeSH terminology and free text words to increase the sensitivity of the search. The keywords for the search in these databases included: "Long noncoding RNA", "lncRNA", "LincRNA", "Long ncRNA", "survival" and cervix (or cervical) cancer/neoplasm/tumour/carcinoma. Meanwhile, we screened the references of retrieved relevant articles to identify potentially eligible literatures.

Inclusion and exclusion criteria {#s4_2}
--------------------------------

Literatures included in this meta-analysis had to meet the following inclusion criteria: studies about the association between lncRNAs expression in tissues or blood samples and prognosis of patients with cervical cancer; the survival outcomes were performed with OS or EFS including disease free survival DFS and RFS; patients were divided into high and low expression groups; sufficient published data were provided to calculate hazard ratios (HR) and 95% confidence interval (CI). Exclusion criteria were as follow: studies without usable or sufficient data; laboratory articles, reviews, letters, unpublished data and conference abstracts.

Data extraction {#s4_3}
---------------

Two investigators (Xiangrong Cui and Xuan Jing) extracted relevant data independently using predesigned and standardized form from the eligible studies. Extracted information included title, authors' names, the nationality and ethnicity of study population, lncRNAs, case number, methodological information and cut-off value. Disagreements were resolved through group discussion.

Statistical methods {#s4_4}
-------------------

HRs and 95% CIs were calculated to assess to the relation between lncRNAs and survival in cervical cancer, with a significance level of α = 0.05. An observed HR \> 1 implied a worse survival for the group with elevated lncRNAs expression. Conversely, HR \< 1 implied a worse survival for the group with decreased lncRNAs expression \[[@R35], [@R36]\]. We used Revman5.3 Software (Revman, the Cochrane Collaboration) to perform the meta-analysis and evaluate heterogeneity between studies by Cochrance *Q*-test and *P*-values. If heterogeneity was present (I^2^ ≥ 50% or *P* ≤ 0.05), random-effect model was used to calculate pooled HRs or ORs, otherwise, the fixed-effect model was utilized \[[@R37], [@R38]\]. Furthermore, we minimized the influence of heterogeneity through classifying the included studies into subgroups accorded to similar features. The Stata 11.0 Software (Stata, College Station) was performed to evaluate the sensitivity and publication bias of the studies. Publication bias was estimated using Begg's test with a funnel plot, *P* \< 0.05 was considered statistically significant.
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